MONMOUTH JUNCTION, N.J., Feb. 2 /PRNewswire/ -- INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
As the developer of this generic injectable drug, INNOPHARMA ent
http://digg.com/u1MA51
No comments:
Post a Comment